Cipla inches up on plan to invest Rs 500 crore to set up API facilities

06 Aug 2012 Evaluate

Cipla is currently trading at Rs. 350.15, up by 0.20 points or 0.06% from its previous closing of Rs. 349.95 on the BSE.

The scrip opened at Rs. 352.00 and has touched a high and low of Rs. 355.00 and Rs. 350.00 respectively. So far 45144 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 363.60 on 01-Aug-2012 and a 52 week low of Rs. 273.60 on 06-Sep-2011.

Last one week high and low of the scrip stood at Rs. 363.60 and Rs. 328.35 respectively. The current market cap of the company is Rs. 28379.26 crore.

The promoters holding in the company stood at 36.80% while Institutions and Non-Institutions held 34.23% and 28.73% respectively. 

Pharma major, Cipla is planning to invest Rs 500 crore for setting up active pharmaceutical ingredients (API) facilities at Patalganga, Bengaluru and Kurkumbh. The company aims to complete setting up of these facilities by 2012-13.

The company is in the process of developing bio-similar/ bio-therapeutic products through its partners in China. It is expected that the clinical trials on these drugs will be completed in 2-3 years and subsequently, the products will be launched in India.

On standalone basis, the company has reported a surge of 58.19% in its net profit at Rs 400.76 crore for the quarter, as compared to Rs 253.34 crore for the same quarter in the previous year. Total income of the company has increased by 23.85% to Rs 2011.25 crore for the quarter under review as compared to Rs 1623.98 crore for the quarter ended June 30, 2011.

Cipla Share Price

1477.15 -1.20 (-0.08%)
28-May-2024 15:49 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1464.85
Dr. Reddys Lab 5955.65
Cipla 1477.15
Zydus Lifesciences 1050.35
Lupin 1603.55
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.